UK Trial Inclusion and Diversity Plans to Have ‘Wider Scope’ Than Those in US
ニュース記事
薬事規制関連支援サービス
The UK’s inclusion and diversity plan will ask “researchers to consider [aspects] beyond participant’s race and ethnicity.”
About the author
Vibha Sharma
Senior Writer
Vibha Sharma is a senior writer covering pharmaceutical and medtech regulatory developments across the globe. She plays a key role in tracking and writing about news of important regulatory issues affecting the sectors and explaining their implications for industry. Her fields of interest include the EU regulations on clinical trials, pharmacovigilance and pediatrics, on which she has written several exclusive articles from various industry conferences. She has also commissioned pieces of expert analysis on major developments in the pharma and medtech regulatory arenas.
DEC 12, 2023
インフォグラフィック
研究開発支援サービス
Make Diverse Trial Recruitment & Enrollment a Priority ― and a Success
Clinical trial sponsors can successfully recruit diverse populations by leveraging the right intelligence to support optimal investigator & site selection. Sitetrove enables sponsors to understand the landscape of clinically relevant and demographically diverse patient populations for US investigators. Patient age, race and gender demographics, can be viewed at the state, city, investigator, and primary organization
levels.